Investor and Financial Strategy for Life Sciences Startups

Session #2: Investor and Financial Strategy for Life Sciences Startups
Get a 360-degree view of the financial aspects of your clinical trial — our panel of experts includes successful entrepreneurs, influential venture investors, and authorities in translational science and clinical development.

Topics
• Risk mitigation/de-risking strategy

• Reimbursement and legal considerations

• Budgeting – Cost expenditures

• Business planning and financial projections

• Best ways to raise capital and prepare for a large investment

• Big company/small company partnerships for funding studies

• Journey of medical device/therapeutic

Agenda
12:00pm – 12:30pm: Opening Remarks

12:05pm – 12:10pm: Panelist Introductions

12:10pm – 1:10pm: Panel Discussion

1:10pm – 1:25pm: Q&A

1:25pm – 1:30pm: Closing Remarks

Panelists
Nancy Briefs – President & CEO, AltrixBio Inc.; Entrepreneur in Residence, UMass M2D2
Daniel Gottlieb – Associate Director, Broadview Ventures
Bill Yelle – Entrepreneur in Residence, Mass General Brigham Ventures
Vinit Nijhawan – Managing Director, MassVentures
Anna O’Rourke – Senior Advisor and SME of Clinical Development, Biomedical Advanced Research and Development Authority
Moderator: Nathaniel Hafer – Director of UMass Center for Clinical and Translational Science, UMass Medical